Skip to main content
. 2020 Apr 16;24(10):5528–5541. doi: 10.1111/jcmm.15209

Table 3.

Genes that are differentially expressed by IPoC‐R and IPoC‐NR and its comparison to IPC

Protein I/R IPoC‐R IPoC‐NR IPC
Regulated by all three conditionings (n = 3)
Arrestin‐β2 1.97 ± 0.42 0.38 ± 0.36*** 0.71 ± 0.50* 0.79 ± 0.55*
FOXn3 1.48 ± 0.18 0.68 ± 0.35** 0.74 ± 0.38* 0.55 ± 0.17***
Zbtb20 0.77 ± 0.14 0.35 ± 0.19* 0.37 ± 0.16* 0.45 ± 0.15*
Selectively Regulated by IPoC‐R and IPoC‐NR but not by IPC (n = 3)
EFhd2 2.49 ± 0.66 0.33 ± 0.15** 1.03 ± 0.59* 1.03 ± 0.83
GRK2 1.39 ± 0.13 0.05 ± 0.02*** 0.46 ± 0.31** 0.95 ± 0.51
VEGF‐A 0.69 ± 0.04 1.60 ± 0.23** 1.65 ± 0.20** 0.90 ± 0.50
Selectively Regulated by IPoC‐R and IPC (n = 7)
Coll‐3 4.26 ± 0.65 0.30 ± 0.13** 2.06 ± 1.85 0.48 ± 0.37**
Elastin 3.02 ± 0.14 0.56 ± 0.34*** 2.69 ± 1.24 0.54 ± 0.40**
Psme3 1.31 ± 0.34 0.61 ± 0.27* 0.74 ± 0.24 0.60 ± 0.10*
Arginase‐1 1.18 ± 0.18 0.14 ± 0.05** 1.02 ± 0.77 0.33 ± 0.19**
CaSR 0.89 ± 0.34 0.05 ± 0.01* 0.32 ± 0.22 0.15 ± 0.09*
Bcl‐2 0.82 ± 0.15 0.36 ± 0.09* 0.75 ± 0.05 0.36 ± 0.09*
Intermedin 0.71 ± 0.30 0.03 ± 0.01* 0.35 ± 0.31 0.09 ± 0.05*
Selectively Regulated by IPoC‐R (n = 21)
Biglycan 4.64 ± 0.85 0.89 ± 0.82*** 2.90 ± 1.75 2.17 ± 2.42
Coll‐1 3.62 ± 0.97 0.79 ± 0.75** 1.85 ± 1.20 1.76 ± 1.80
NOX2 2.43 ± 1.19 0.05 ± 0.02* 0.52 ± 0.72 0.12 ± 0.10
Fibronectin 2.13 ± 0.83 0.40 ± 0.42* 1.24 ± 0.87 1.36 ± 1.52
JDP2 1.76 ± 0.47 0.44 ± 0.30** 1.11 ± 0.65 1.52 ± 0.45
TGF‐β1 1.71 ± 0.15 0.54 ± 0.32** 1.24 ± 0.67 1.36 ± 0.13
RAMP‐1 1.32 ± 0.39 0.17 ± 0.07* 0.77 ± 0.51 0.29 ± 0.09
PTHrP 1.24 ± 0.52 0.20 ± 0.06* 0.76 ± 0.11 0.62 ± 0.35
RAMP‐3 1.17 ± 0.43 0.29 ± 0.09* 0.74 ± 0.50 1.19 ± 0.73
iNOS 1.09 ± 0.03 0.39 ± 0.14** 0.92 ± 0.29 0.77 ± 0.34
Arginase‐2 1.05 ± 0.18 0.21 ± 0.10*** 0.61 ± 0.35 0.80 ± 0.48
Arrestin‐β1 1.05 ± 0.35 0.29 ± 0.31* 0.58 ± 0.29 0.49 ± 0.27
eNOS 1.03 ± 0.08 0.50 ± 0.11*** 0.73 ± 0.20 0.74 ± 0.48
RAMP‐2 0.98 ± 0.35 0.26 ± 0.05* 0.65 ± 0.32 0.74 ± 0.50
GRK5 0.97 ± 0.15 0.28 ± 0.13*** 0.59 ± 0.28 0.76 ± 0.38
MDM2 0.94 ± 0.17 0.48 ± 0.22* 0.67 ± 0.36 1.25 ± 0.64
SDF‐1α 0.90 ± 0.15 0.29 ± 0.21** 0.50 ± 0.20 1.21 ± 1.07
Oxsr1 0.75 ± 0.18 0.36 ± 0.15* 0.48 ± 0.28 0.41 ± 0.19
Ppargc1b 0.71 ± 0.25 0.23 ± 0.15* 0.25 ± 0.16 0.31 ± 0.09
SERCA2a 0.70 ± 0.16 9.74 ± 4.74* 5.02 ± 5.34 2.99 ± 2.47
AR‐B2 0.68 ± 0.04 0.26 ± 0.06*** 0.68 ± 0.27 0.68 ± 0.04
PLB 0.41 ± 0.04 1.74 ± 0.47 0.99 ± 0.75 1.66 ± 0.49
Socs7 0.19 ± 0.05 0.05 ± 0.03* 0.12 ± 0.12 0.19 ± 0.18

Abbreviations: AR, adrenoceptor; bcl, B‐cell lymphoma; CaSR, calcium sensing receptor; Coll, collagen; EFhd, EF‐hand domain; FOX, forkhead box protein; GRK, G‐protein coupled receptor; JDP2, jun dimerization protein; MDM mouse double minute; NOS, nitric oxide synthase; NOX, NADPH oxidase; Oxsr, oxidative stress response; PLB, phospholamban; Ppargc, peroxisome proliferator‐activated receptor gamma co‐activator gamma; Psme, proteome activator subunit; PTHrP, parathyroid hormone‐related protein; RAMP, receptor activator modifying protein; SDF, stromal derived factor; SERCA, sarcoplamatic reticulum receptor calcium ATPase; Socs, Supressor of cytokine signalling; TGF, transforming growth factor; VEGF, vascular endothelial growth factor; Zbtb, Zinc‐finger and BTB‐containing protein.

*

P < .05 vs I/R

**

P < .01 vs I/R

***

P < .001 vs I/R.